CN106283198A - 用于单细胞全基因组重亚硫酸氢盐测序的文库构建方法 - Google Patents
用于单细胞全基因组重亚硫酸氢盐测序的文库构建方法 Download PDFInfo
- Publication number
- CN106283198A CN106283198A CN201610701005.6A CN201610701005A CN106283198A CN 106283198 A CN106283198 A CN 106283198A CN 201610701005 A CN201610701005 A CN 201610701005A CN 106283198 A CN106283198 A CN 106283198A
- Authority
- CN
- China
- Prior art keywords
- chain
- article
- unicellular
- library
- constructing method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 47
- 238000001369 bisulfite sequencing Methods 0.000 title claims abstract description 18
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 28
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 25
- 238000010276 construction Methods 0.000 claims abstract description 9
- 230000008569 process Effects 0.000 claims abstract description 8
- 238000000746 purification Methods 0.000 claims abstract description 6
- 238000005336 cracking Methods 0.000 claims abstract description 5
- 239000011324 bead Substances 0.000 claims description 34
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 29
- 108020004414 DNA Proteins 0.000 claims description 24
- 239000003153 chemical reaction reagent Substances 0.000 claims description 23
- 229960002685 biotin Drugs 0.000 claims description 15
- 235000020958 biotin Nutrition 0.000 claims description 15
- 239000011616 biotin Substances 0.000 claims description 15
- 238000012360 testing method Methods 0.000 claims description 10
- 238000012408 PCR amplification Methods 0.000 claims description 8
- 108010090804 Streptavidin Proteins 0.000 claims description 5
- 230000029087 digestion Effects 0.000 claims description 5
- 102000053602 DNA Human genes 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 4
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 2
- 238000012163 sequencing technique Methods 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 9
- 239000000376 reactant Substances 0.000 description 7
- 230000007067 DNA methylation Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000001179 sorption measurement Methods 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 101100533230 Caenorhabditis elegans ser-2 gene Proteins 0.000 description 4
- 239000012148 binding buffer Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 108010007577 Exodeoxyribonuclease I Proteins 0.000 description 3
- 102100029075 Exonuclease 1 Human genes 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000012149 elution buffer Substances 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108010019644 Oligodendrocyte Transcription Factor 2 Proteins 0.000 description 2
- 102100026073 Oligodendrocyte transcription factor 1 Human genes 0.000 description 2
- 101710195940 Oligodendrocyte transcription factor 1 Proteins 0.000 description 2
- 102100026058 Oligodendrocyte transcription factor 2 Human genes 0.000 description 2
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 229960001570 ademetionine Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 1
- 102100036279 DNA (cytosine-5)-methyltransferase 1 Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 101000931098 Homo sapiens DNA (cytosine-5)-methyltransferase 1 Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000055027 Protein Methyltransferases Human genes 0.000 description 1
- 108700040121 Protein Methyltransferases Proteins 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical class OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000011365 genetic imprinting Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 238000003805 vibration mixing Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Sample | GT1 | GT2 | Ser1 | Ser2 | N |
Clean Reads | 15,423,792 | 19,375,360 | 15,447,641 | 15,544,734 | 12,726,610 |
Unique Mapped Reads | 4,212,814 | 6,209,534 | 2,825,097 | 3,980,617 | 75,022 |
Unique Mapped Ratio(%) | 27.3 | 32 | 18.3 | 25.6 | 0.6 |
Insert Size(bp) | 163.19 | 158.65 | — | — | 158.48 |
Error Rate(%) | 5.82 | 1.69 | — | — | 1.94 |
Dup Ratio(%) | 23.09 | 9.78 | 28.8 | 32.6 | 34.68 |
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2015110306145 | 2015-12-31 | ||
CN201511030614 | 2015-12-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106283198A true CN106283198A (zh) | 2017-01-04 |
CN106283198B CN106283198B (zh) | 2021-08-13 |
Family
ID=57662253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610701005.6A Active CN106283198B (zh) | 2015-12-31 | 2016-08-22 | 用于单细胞全基因组重亚硫酸氢盐测序的文库构建方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106283198B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110305946A (zh) * | 2019-07-18 | 2019-10-08 | 重庆大学附属肿瘤医院 | 基于高通量测序的dna甲基化检测方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102409049A (zh) * | 2010-09-21 | 2012-04-11 | 深圳华大基因科技有限公司 | 一种基于pcr的dna标签文库构建方法 |
CN103088433A (zh) * | 2011-11-02 | 2013-05-08 | 深圳华大基因科技有限公司 | 全基因组甲基化高通量测序文库的构建方法及其应用 |
CN104532360A (zh) * | 2014-12-17 | 2015-04-22 | 北京诺禾致源生物信息科技有限公司 | 全基因组甲基化测序文库及其构建方法 |
-
2016
- 2016-08-22 CN CN201610701005.6A patent/CN106283198B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102409049A (zh) * | 2010-09-21 | 2012-04-11 | 深圳华大基因科技有限公司 | 一种基于pcr的dna标签文库构建方法 |
CN103088433A (zh) * | 2011-11-02 | 2013-05-08 | 深圳华大基因科技有限公司 | 全基因组甲基化高通量测序文库的构建方法及其应用 |
CN104532360A (zh) * | 2014-12-17 | 2015-04-22 | 北京诺禾致源生物信息科技有限公司 | 全基因组甲基化测序文库及其构建方法 |
Non-Patent Citations (2)
Title |
---|
HONGSHAN GUO ET AL.: "Profiling DNA methylome landscapes of mammalian cells with single-cell reduced-representation bisulfite sequencing", 《NATURE PROTOCOLS》 * |
SÉBASTIEN A SMALLWOOD ET AL.: "Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity", 《NATURE METHODS》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110305946A (zh) * | 2019-07-18 | 2019-10-08 | 重庆大学附属肿瘤医院 | 基于高通量测序的dna甲基化检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106283198B (zh) | 2021-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020202992B2 (en) | Methods for genome assembly and haplotype phasing | |
Blumenstiel et al. | Targeted exon sequencing by in‐solution hybrid selection | |
CN105861700B (zh) | 一种针对神经肌肉病的高通量检测方法 | |
CN113308562B (zh) | 棉花全基因组40k单核苷酸位点及其在棉花基因分型中的应用 | |
CA2439098A1 (en) | Mutation detection using muts and reca | |
AU2002311761A1 (en) | Mutation detection using MutS and RecA | |
Smallwood et al. | Genome-wide analysis of DNA methylation in low cell numbers by reduced representation bisulfite sequencing | |
CN110853708A (zh) | 用于hla分型的核酸捕获探针的设计方法 | |
CN109295500B (zh) | 一种单细胞甲基化测序技术及其应用 | |
Erfle et al. | Mutational specificity: An efficient laboratory protocol for the sequencing of large numbers of lacl mutants recovered from Big Blue® transgenic animals | |
CN106283198A (zh) | 用于单细胞全基因组重亚硫酸氢盐测序的文库构建方法 | |
Jun | DNA chemical damage and its detected | |
Zhang et al. | On-chip oligonucleotide ligation assay using one-dimensional microfluidic beads array for the detection of low-abundant DNA point mutations | |
JP2008104443A (ja) | Dnaメチル化測定方法 | |
CN110452958A (zh) | 一种微量碎片化核酸甲基化检测的接头、引物、试剂盒及其应用 | |
Biasini et al. | A protocol for transcriptome-wide inference of RNA metabolic rates in mouse embryonic stem cells | |
CN110600082B (zh) | 用于hla分型的核酸捕获探针及其设计方法 | |
KR101683086B1 (ko) | 유전자의 발현량 및 메틸화 프로필을 활용한 돼지의 산자수 예측방법 | |
Kiefer | Genome-wide analysis of methylation in bovine clones by methylated DNA immunoprecipitation (MeDIP) | |
CN111718981A (zh) | Ace基因检测引物组、检测试剂盒及检测方法 | |
CN111718986A (zh) | Ptgs1基因检测引物组、检测试剂盒及检测方法 | |
CN113490750B (zh) | 微量dna甲基化高通量测序方法 | |
Yokomori et al. | A multiplex RNA quantification method to determine the absolute amounts of mRNA without reverse transcription | |
CN116769783B (zh) | 一种特异性识别志贺毒素ⅱ型b亚基的核酸适配体及其应用 | |
Wawrzyniak-Turek et al. | Enzymatic combinatorial nucleoside deletion scanning mutagenesis of functional RNA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171225 Address after: 100176 Beijing branch of Beijing economic and Technological Development Zone Street 88 Hospital No. 8 Building 2 unit 701 room Applicant after: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. Applicant after: ZHEJIANG ANNOROAD BIO-TECHNOLOGY Co.,Ltd. Applicant after: ANNOROAD (YIWU) MEDICAL INSPECTION CO.,LTD. Address before: 100176 Beijing City, Daxing District branch of Beijing economic and Technological Development Zone Street 88 Hospital No. 8 Building 2 unit 701 room Applicant before: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210712 Address after: 322000 1st floor, building 9, standard workshop, No.10 Gaoxin Road, Houjiang street, Yiwu City, Jinhua City, Zhejiang Province Applicant after: ZHEJIANG ANNOROAD BIO-TECHNOLOGY Co.,Ltd. Applicant after: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. Applicant after: ANNOROAD (YIWU) MEDICAL INSPECTION CO.,LTD. Address before: 100176 room 701, unit 2, building 8, courtyard 88, Kechuang 6th Street, Beijing Economic and Technological Development Zone, Beijing Applicant before: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. Applicant before: ZHEJIANG ANNOROAD BIO-TECHNOLOGY Co.,Ltd. Applicant before: ANNOROAD (YIWU) MEDICAL INSPECTION CO.,LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240621 Address after: Room 101 and 201, Unit 2, Building 8, No. 88 Kechuang 6th Street, Beijing Economic and Technological Development Zone, Daxing District, Beijing, 100176 Patentee after: BEIJING ANNOROAD MEDICAL LABORATORY Co.,Ltd. Country or region after: China Patentee after: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. Address before: 322000 1st floor, building 9, standard workshop, No.10 Gaoxin Road, Houjiang street, Yiwu City, Jinhua City, Zhejiang Province Patentee before: ZHEJIANG ANNOROAD BIO-TECHNOLOGY Co.,Ltd. Country or region before: China Patentee before: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. Patentee before: ANNOROAD (YIWU) MEDICAL INSPECTION CO.,LTD. |
|
TR01 | Transfer of patent right |